Home  >  Products  >  Slamf1 (signaling lymphocytic activation molecule family member 1 ) Blocking Peptide (the middle region of Slamf1)(100ug)
Slamf1 (signaling lymphocytic activation molecule family member 1 ) Blocking Peptide (the middle region of Slamf1)(100ug)

Slamf1 (signaling lymphocytic activation molecule family member 1 ) Blocking Peptide (the middle region of Slamf1)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-Slamf1 Antibody (ARP62712_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human, Mouse
Presku: AAP62712
Size: 100ug
Weight: 38kDa
Gene: 27218
Format: Lyophilized powder
Target: Slamf1 is a high-affinity self-ligand important in bidirectional T-cell to B-cell stimulation. SLAM-induced signal-transduction events in T-lymphocytes are different from those in B-cells. Two modes of SLAM signaling are likely to exist: one in which the inhibitor SH2D1A acts as a negative regulator and another in which protein-tyrosine phosphatase 2C (PTPN11)-dependent signal transduction operates.
Alternative names: 4933415F16; AA177906; CD150; CDw150; ESTM51; IPO-3; Slam
See Full Product Listings >